Roopa Kanakatti Shankar, M.D.

Division of Endocrinology, Children’s National Hospital
Washington, United States

Disclosure information not submitted.

Presentation(s):

• ORF47-08 - Vosoritide Treatment in Children with Hypochondroplasia: Three-Year Results from A Phase II Extension Trial

  Monday, June 15, 2026
  3:00 PM - 3:15 PM CT